Rheumatoid Arthritis Clinical Trials in New York

Showing 2281-2300 of 3,596 trials

Selinexor in Combination With Ixazomib for the Treatment of Advanced Sarcoma

NCT03880123

The main purpose of this study is to establish a safe and tolerable dose combination (the "maximum tolerated dose") of selinexor and ixazomib when used together for the treatment of patients with certain types of advanced sarcoma. The study will enroll patients with advanced dedifferentiated liposarcoma, malignant peripheral nerve sheath tumor, alveolar soft part sarcoma and Ewing sarcoma. Future studies to further evaluate the safety and anti-cancer efficacy of this treatment for sarcoma will use the dose combination determined in this study.

LiposarcomaMalignant Peripheral Nerve Sheath TumorsAlveolar Soft Part Sarcoma+2 more

Matthew InghamStarted Nov 2020

New York, New York, United States

COMPLETEDPhase 1< 1 mile

A Study to Test the Combination of Selinexor (KPT-330), Ixazomib, and Dexamethasone in Patients With Myeloma

NCT02831686

The purpose of this study is to test the safety of a combination of study drugs called selinexor (KPT-330) and ixazomib (MLN9708) with a low dose of dexamethasone. This study tests different doses of the study drug, selinexor to see which dose is safer in people. Depending on which group (dose level) you are in, the dose of selinexor will vary, but the ixazomib and dexamethasone doses will be the same among the groups.

Multiple MyelomaRelapsed and/or Refractory Multiple Myeloma

Memorial Sloan Kettering Cancer Center18 participantsStarted Jul 2016

Basking Ridge, New Jersey, United States • Middletown, New Jersey, United States • Montvale, New Jersey, United States +4 more locations

Selinexor in Combination With Ixazomib for the Treatment of Advanced Sarcoma

A Study to Test the Combination of Selinexor (KPT-330), Ixazomib, and Dexamethasone in Patients With Myeloma

Rheumatoid Arthritis Trials in Other Cities

Use of Low Cost Prostheses to Improve Upper Extremity Function in Children With Cerebral Palsy

A Randomized Study of Sulindac in Oral Premalignant Lesions

First Line Gemcitabine, Cisplatin and MEK162 in Advanced Biliary Tract Carcinoma

Polysomnography-directed Noninvasive Ventilation in Amyotrophic Lateral Sclerosis (ALS)

Occipital Nerve Stimulation (ONS) for Migraine: OPTIMISE

Lumbar Manipulation for Hip and Muscle Strength

Clinical Investigation of New CI Delivery Models in an Adult Nucleus CI Population

Study of Intravitreal REGN2176-3 in Participants With Neovascular ("Wet") Age-Related Macular Degeneration (AMD)

Study to Evaluate the Safety and Effectiveness of the CODMAN ENTERPRISE® Vascular Reconstruction Device

Megestrol in Treating Patients With Endometrial Neoplasia or Endometrial Hyperplasia

TRANSFIX Zenith® Transection Clinical Study

Radiation Therapy in Treating Patients With Stage II or Stage III Oropharyngeal Cancer

Revolution™ Peripheral Atherectomy System for Lower Extremity Peripheral Arterial Revascularization

Sleep Apnea in TIA/Stroke: Reducing Cardiovascular Risk With Positive Airway Pressure

Fixation Using Alternative Implants for the Treatment of Hip Fractures (FAITH-2)

Safety and Efficacy of Melflufen and Dexamethasone in Relapsed and/or Relapsed-Refractory Multiple Myeloma Patients

Dose-finding Study of GLPG0634 as add-on to Methotrexate in Active Rheumatoid Arthritis Participants (DARWIN1)

Clinical Study to Assess the Pharmacokinetics, Safety and Tolerability of Single and Multiple Oral Doses of AFQ056 in Children With Fragile X Syndrome (FXS)

Other Conditions in New York